Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 12 |
NetGPI | no | yes: 0, no: 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 1 |
GO:0003677 | DNA binding | 4 | 1 |
GO:0005488 | binding | 1 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 150 | 152 | PF00675 | 0.648 |
CLV_NRD_NRD_1 | 186 | 188 | PF00675 | 0.496 |
CLV_NRD_NRD_1 | 20 | 22 | PF00675 | 0.442 |
CLV_NRD_NRD_1 | 5 | 7 | PF00675 | 0.352 |
CLV_PCSK_KEX2_1 | 150 | 152 | PF00082 | 0.648 |
CLV_PCSK_KEX2_1 | 185 | 187 | PF00082 | 0.512 |
CLV_PCSK_KEX2_1 | 20 | 22 | PF00082 | 0.442 |
CLV_PCSK_KEX2_1 | 5 | 7 | PF00082 | 0.352 |
CLV_PCSK_KEX2_1 | 71 | 73 | PF00082 | 0.393 |
CLV_PCSK_PC1ET2_1 | 71 | 73 | PF00082 | 0.393 |
CLV_PCSK_SKI1_1 | 115 | 119 | PF00082 | 0.377 |
CLV_PCSK_SKI1_1 | 12 | 16 | PF00082 | 0.402 |
CLV_PCSK_SKI1_1 | 89 | 93 | PF00082 | 0.459 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.383 |
DEG_SCF_FBW7_2 | 240 | 246 | PF00400 | 0.427 |
DOC_CKS1_1 | 240 | 245 | PF01111 | 0.433 |
DOC_CKS1_1 | 63 | 68 | PF01111 | 0.340 |
DOC_CYCLIN_RxL_1 | 228 | 236 | PF00134 | 0.558 |
DOC_CYCLIN_yCln2_LP_2 | 237 | 243 | PF00134 | 0.381 |
DOC_MAPK_JIP1_4 | 122 | 128 | PF00069 | 0.452 |
DOC_PP2B_LxvP_1 | 237 | 240 | PF13499 | 0.370 |
DOC_USP7_MATH_1 | 138 | 142 | PF00917 | 0.444 |
DOC_WW_Pin1_4 | 239 | 244 | PF00397 | 0.427 |
DOC_WW_Pin1_4 | 62 | 67 | PF00397 | 0.333 |
DOC_WW_Pin1_4 | 80 | 85 | PF00397 | 0.402 |
LIG_14-3-3_CanoR_1 | 202 | 208 | PF00244 | 0.489 |
LIG_14-3-3_CanoR_1 | 48 | 52 | PF00244 | 0.502 |
LIG_Actin_WH2_2 | 56 | 73 | PF00022 | 0.378 |
LIG_FHA_1 | 228 | 234 | PF00498 | 0.517 |
LIG_FHA_1 | 250 | 256 | PF00498 | 0.374 |
LIG_FHA_2 | 134 | 140 | PF00498 | 0.430 |
LIG_FHA_2 | 240 | 246 | PF00498 | 0.395 |
LIG_LIR_Apic_2 | 133 | 138 | PF02991 | 0.465 |
LIG_LIR_Gen_1 | 232 | 243 | PF02991 | 0.537 |
LIG_LIR_Gen_1 | 25 | 36 | PF02991 | 0.347 |
LIG_LIR_Nem_3 | 133 | 137 | PF02991 | 0.402 |
LIG_LIR_Nem_3 | 2 | 7 | PF02991 | 0.350 |
LIG_LIR_Nem_3 | 232 | 238 | PF02991 | 0.548 |
LIG_LIR_Nem_3 | 25 | 31 | PF02991 | 0.353 |
LIG_LIR_Nem_3 | 252 | 257 | PF02991 | 0.394 |
LIG_PTB_Apo_2 | 128 | 135 | PF02174 | 0.389 |
LIG_PTB_Apo_2 | 34 | 41 | PF02174 | 0.342 |
LIG_PTB_Phospho_1 | 34 | 40 | PF10480 | 0.341 |
LIG_SH2_CRK | 4 | 8 | PF00017 | 0.331 |
LIG_SH2_NCK_1 | 135 | 139 | PF00017 | 0.454 |
LIG_SH2_SRC | 95 | 98 | PF00017 | 0.386 |
LIG_SH2_STAP1 | 40 | 44 | PF00017 | 0.345 |
LIG_SH2_STAT3 | 40 | 43 | PF00017 | 0.344 |
LIG_SH2_STAT5 | 135 | 138 | PF00017 | 0.417 |
LIG_SH2_STAT5 | 212 | 215 | PF00017 | 0.420 |
LIG_SH2_STAT5 | 241 | 244 | PF00017 | 0.406 |
LIG_SH2_STAT5 | 34 | 37 | PF00017 | 0.360 |
LIG_SH3_3 | 237 | 243 | PF00018 | 0.455 |
MOD_CK1_1 | 141 | 147 | PF00069 | 0.404 |
MOD_CK1_1 | 266 | 272 | PF00069 | 0.505 |
MOD_CK2_1 | 133 | 139 | PF00069 | 0.426 |
MOD_NEK2_1 | 249 | 254 | PF00069 | 0.484 |
MOD_NEK2_2 | 203 | 208 | PF00069 | 0.414 |
MOD_PKA_2 | 47 | 53 | PF00069 | 0.489 |
MOD_Plk_1 | 138 | 144 | PF00069 | 0.409 |
MOD_Plk_2-3 | 133 | 139 | PF00069 | 0.409 |
MOD_Plk_4 | 263 | 269 | PF00069 | 0.508 |
MOD_Plk_4 | 47 | 53 | PF00069 | 0.489 |
MOD_ProDKin_1 | 239 | 245 | PF00069 | 0.421 |
MOD_ProDKin_1 | 62 | 68 | PF00069 | 0.335 |
MOD_ProDKin_1 | 80 | 86 | PF00069 | 0.400 |
MOD_SUMO_rev_2 | 107 | 113 | PF00179 | 0.399 |
TRG_DiLeu_BaLyEn_6 | 245 | 250 | PF01217 | 0.363 |
TRG_ENDOCYTIC_2 | 114 | 117 | PF00928 | 0.347 |
TRG_ENDOCYTIC_2 | 241 | 244 | PF00928 | 0.391 |
TRG_ENDOCYTIC_2 | 4 | 7 | PF00928 | 0.339 |
TRG_ER_diArg_1 | 149 | 151 | PF00400 | 0.612 |
TRG_ER_diArg_1 | 184 | 187 | PF00400 | 0.448 |
TRG_ER_diArg_1 | 20 | 22 | PF00400 | 0.444 |
TRG_ER_diArg_1 | 220 | 223 | PF00400 | 0.470 |
TRG_ER_diArg_1 | 4 | 6 | PF00400 | 0.347 |
TRG_ER_diArg_1 | 72 | 75 | PF00400 | 0.398 |
TRG_Pf-PMV_PEXEL_1 | 103 | 107 | PF00026 | 0.397 |
TRG_Pf-PMV_PEXEL_1 | 20 | 25 | PF00026 | 0.434 |
TRG_Pf-PMV_PEXEL_1 | 231 | 236 | PF00026 | 0.554 |
TRG_Pf-PMV_PEXEL_1 | 281 | 285 | PF00026 | 0.421 |
TRG_Pf-PMV_PEXEL_1 | 292 | 296 | PF00026 | 0.493 |
TRG_Pf-PMV_PEXEL_1 | 5 | 9 | PF00026 | 0.332 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PCB7 | Leptomonas seymouri | 81% | 100% |
A0A0S4IJG6 | Bodo saltans | 58% | 93% |
A0A1X0NT90 | Trypanosomatidae | 71% | 99% |
A0A381MHF5 | Leishmania infantum | 98% | 100% |
A0A3Q8IAP3 | Leishmania donovani | 98% | 100% |
A0A3S7WX26 | Leishmania donovani | 98% | 100% |
A0A422NDI7 | Trypanosoma rangeli | 73% | 100% |
A4HCB5 | Leishmania braziliensis | 93% | 100% |
C9ZSF8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 69% | 100% |
E9AVQ5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 98% | 82% |
V5DMI7 | Trypanosoma cruzi | 71% | 90% |